NuCana (NCNA) EBT (2017 - 2025)
NuCana (NCNA) reported EBT of -$3.5 million for Q4 2025, down 244.62% on a YoY basis from $2.4 million in Q4 2024, and down 313.68% sequentially from -$844700.7 in Q3 2025.
NuCana (NCNA) EBT (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 9 years of EBT data on file, last reported at -$3.5 million in Q4 2025.
- For the quarter ending Q4 2025, EBT fell 244.62% year-over-year to -$3.5 million; the trailing twelve-month figure through Dec 2025 stood at -$40.5 million (down 41.62% YoY), and the FY2025 full-year result was -$40.2 million, down 40.22% from the prior year.
- EBT retreated to -$3.5 million in Q4 2025, from -$844700.7 in the prior quarter.
- In the past five years, EBT ranged from a high of -$844700.7 in Q3 2025 to a low of -$32.6 million in Q2 2025.
- A 5-year average of -$11.1 million and a median of -$10.4 million in 2024 frame the typical range for EBT.
- Across the five-year window, EBT surged 90.89% in 2024 and tumbled 244.62% in 2025, its largest moves.
- Tracing NCNA's EBT over 5 years: stood at -$21.2 million in 2021, then advanced by 6.1% to -$19.9 million in 2022, then jumped by 44.03% to -$11.1 million in 2023, then surged by 90.89% to -$1.0 million in 2024, then plunged by 244.62% to -$3.5 million in 2025.
- Business Quant data shows NCNA's EBT at -$3.5 million in Q4 2025, -$844700.7 in Q3 2025, and -$32.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | NuCana | 14.60 Bn | 14.60 Bn | - | -3.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.49 Mn |
| Sep 30, 2025 | -844,700.70 |
| Jun 30, 2025 | -32.61 Mn |
| Mar 31, 2025 | -3.56 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Sep 30, 2024 | -6.82 Mn |
| Jun 30, 2024 | -10.43 Mn |
| Mar 31, 2024 | -10.33 Mn |
| Dec 31, 2023 | -11.13 Mn |
| Sep 30, 2023 | -10.26 Mn |
| Jun 30, 2023 | -7.63 Mn |
| Mar 31, 2023 | -10.77 Mn |
| Dec 31, 2022 | -19.89 Mn |
| Sep 30, 2022 | -7.04 Mn |
| Jun 30, 2022 | -6.40 Mn |
| Mar 31, 2022 | -14.00 Mn |
| Dec 31, 2021 | -21.18 Mn |
| Sep 30, 2021 | -13.72 Mn |
| Jun 30, 2021 | -14.92 Mn |
| Mar 31, 2021 | -15.81 Mn |